These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2868472)

  • 21. Thyroid function alterations following quetiapine initiation in a developmentally disabled adolescent.
    Dobbs RL; Brahm NC; Fast G; Brown RC
    Ann Pharmacother; 2004 Sep; 38(9):1541-2. PubMed ID: 15252194
    [No Abstract]   [Full Text] [Related]  

  • 22. [Behavior problems in adults with mental retardation. Psychopharmaceuticals are used too often--pedagogical efforts would be better].
    Näslund I
    Lakartidningen; 2007 Apr 4-17; 104(14-15):1132-5. PubMed ID: 17472101
    [No Abstract]   [Full Text] [Related]  

  • 23. Risperidone-induced double incontinence.
    Hergüner S; Mukaddes NM
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1085-6. PubMed ID: 18387724
    [No Abstract]   [Full Text] [Related]  

  • 24. Case study of neuroleptic-induced akathisia: important implications for individuals with mental retardation.
    Gross EJ; Hull HG; Lytton GJ; Hill JA; Piersel WC
    Am J Ment Retard; 1993 Jul; 98(1):156-64. PubMed ID: 8103997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment of phenothiazine-induced tachycardia by propranolol.
    Isac M; Stern S; Edelstein EL
    Isr Ann Psychiatr Relat Discip; 1972 Sep; 10(3):272-7. PubMed ID: 4156353
    [No Abstract]   [Full Text] [Related]  

  • 26. Cataract case presentation.
    Klima KA
    Insight; 2006; 31(3):18. PubMed ID: 17253022
    [No Abstract]   [Full Text] [Related]  

  • 27. Ocular changes produced by chlorpromazine.
    Dencker SJ; Enoksson P
    Acta Ophthalmol (Copenh); 1966; 44(3):397-403. PubMed ID: 5953234
    [No Abstract]   [Full Text] [Related]  

  • 28. The prevalence of the ocular side effects of chlorpromazine in the Tuscaloosa Veterans Administration patient population.
    Alexander LJ; Bowerman L; Thompson LR
    J Am Optom Assoc; 1985 Nov; 56(11):872-6. PubMed ID: 4078212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychoactive drugs used with adults and elderly adults who have mental retardation.
    Pary R
    Am J Ment Retard; 1993 Jul; 98(1):121-7. PubMed ID: 8103995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with the successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities.
    Branford D
    J Intellect Disabil Res; 1996 Aug; 40 ( Pt 4)():322-9. PubMed ID: 8884587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine.
    Gualtieri CT; Lefler WH; Guimond M; Staye JI
    Am J Psychiatry; 1982 Sep; 139(9):1178-80. PubMed ID: 7114312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pilot study on oxaflumazine, a new piperazinated phenothiazine].
    Villeneuve A; Dogan K; Lachance R; Drolet A
    Int J Clin Pharmacol; 1972 Aug; 6(3):246-55. PubMed ID: 4405378
    [No Abstract]   [Full Text] [Related]  

  • 33. Systematic dyskinesia examination of profoundly mentally retarded persons: cooperation and assessment.
    Granger DA; Yurkunski JM; Miller NH; Swanson JM; Crinella FC
    Am J Ment Defic; 1987 Sep; 92(2):155-60. PubMed ID: 2893551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular changes associated with chlorpromazine therapy. A preliminary report.
    Edler K
    Acta Ophthalmol (Copenh); 1966; 44(3):405-9. PubMed ID: 5953235
    [No Abstract]   [Full Text] [Related]  

  • 35. Eye changes following phenothiazine administration.
    Garner LL; Wang RI; Hieb E
    Wis Med J; 1974 Sep; 73(9):S119-21. PubMed ID: 4153354
    [No Abstract]   [Full Text] [Related]  

  • 36. Exposure to phenothiazine drugs and risk of cataract.
    Isaac NE; Walker AM; Jick H; Gorman M
    Arch Ophthalmol; 1991 Feb; 109(2):256-60. PubMed ID: 1671548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex differences in long-term adverse effects of phenothiazines.
    Lehmann HE; Ban TA
    Adv Biochem Psychopharmacol; 1974; 9(0):249-54. PubMed ID: 4151763
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ocular involvement during prolonged treatment with neuroleptics].
    Nouri A; Cuendet JF
    Schweiz Med Wochenschr; 1968 Oct; 98(43):1708-11. PubMed ID: 4974196
    [No Abstract]   [Full Text] [Related]  

  • 39. The dexamethasone suppression test as an indication of depression in patients with mental retardation.
    Mattes JA; Amsell L
    Am J Ment Retard; 1993 Nov; 98(3):354-9. PubMed ID: 7904820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experience with leptril therapy for preschool children].
    Semenovskaia EI; Rozengauz RA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(10):1579-82. PubMed ID: 4149525
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.